Delivery Order SPE2DR25D2009-SPE2DR26FJ4V3
- Not listed
- The Defense Logistics Agency awarded a $1,172.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector 2-packs. The award, issued on January 6, 2026, with an ultimate completion date of January 7, 2026, represents a child delivery order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. This contract was competitively awarded with no set-aside designation. AmerisourceBergen...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $1,477.10 and an ultimate completion date of August 25, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract vehicle with the Defense Logistics Agency. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the procurement of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $5,507.40 and a completion date of January 6, 2026. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical supply transaction under the company's broader federal contracting portfolio with DLA. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $3,594.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of epinephrine 0.3 mg auto-injector two-packs, with an ultimate completion date of November 18, 2025. This non-set-aside competitive award was issued on November 17, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $2,341.44 and ultimate completion date of November 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The place of performance is listed as the contractor's corporate office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,094.04 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract is a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, valued at $2,738.77. This is a firm fixed-price delivery order with an ultimate completion date of December 5, 2025, and represents performance at the company's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded without any set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,353.97 delivery order to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector (2-pack) on December 4, 2025, with a completion date of December 5, 2025. This non-competitive, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $4,651.20. This competitive award, executed on a firm fixed-price basis with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract specifies a performance location in Conshohocken,...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ4V3Delivery Order
The Defense Logistics Agency awarded a $2,358.98 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of epinephrine 0.3 mg auto-injector two-packs. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 7, 2026, and performance will be executed from the awardee's facility in Conshohocken, Pennsylvania. The delivery order represents a tactical procurement under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This award is a child delivery order under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at up to $999,999,999.00 through December 2026. The parent company, Cencora, Inc., operates AmerisourceBergen as a critical pharmaceutical distributor serving military healthcare systems, the Defense Health Agency, and other federal medical institutions. The IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical commodities globally, supporting military treatment facilities and veterans' healthcare programs across multiple therapeutic domains. This specific epinephrine auto-injector procurement fulfills immediate medical supply needs within the broader strategic pharmaceutical support framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/5/26 |